Related Experiment Videos
Immunotherapy of metastatic disease
1Program Resources, Inc., National Cancer Institute-Frederick Cancer Research Facility, Maryland.
Seminars in Thrombosis and Hemostasis
|January 1, 1988
Abstract:
It appears that the cytokines have significant therapeutic potential as an adjunct to established therapeutic regimens. It appears that, as single agents, they will have minimal therapeutic activity. However, in minimal residual disease settings or after debulking regimens by surgery, chemotherapy, or radiotherapy, significantly increased therapeutic activity can be expected by the addition of cytokines to treatment protocols.